Article thumbnail

Upregulated MicroRNA-29a by Hepatitis B Virus X Protein Enhances Hepatoma Cell Migration by Targeting PTEN in Cell Culture Model

By Guangyao Kong, Junping Zhang, Shuai Zhang, Changliang Shan, Lihong Ye and Xiaodong Zhang


Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3′UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2010). A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase.
  2. (2009). A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells.
  3. (2007). Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
  4. (2010). Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
  5. (2009). Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
  6. (2001). Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix.
  7. (2006). Effects of hepatitis B virus X protein on the development of liver cancer.
  8. (2005). Epidemiology and natural history of hepatocellular carcinoma.
  9. (2001). Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
  10. (2004). HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.
  11. (2009). HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappaB.
  12. (2004). Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/ AKT pathways: involvement of invasive potential.
  13. (2003). Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
  14. (2010). Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells.
  15. (2005). Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
  16. (2010). MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells.
  17. (2008). Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight?
  18. (2009). MicroRNA 29b functions in acute myeloid leukemia.
  19. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834–838. Upregulated MiR-29a by HBx Enhances Cell Migration PLoS
  20. (2006). MicroRNA signatures in human cancers.
  21. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
  22. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
  23. (2010). microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
  24. (2010). MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein.
  25. (2005). MicroRNAs as oncogenes and tumor suppressors.
  26. (2010). miR-221 overexpression contributes to liver tumorigenesis.
  27. (2009). miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.
  28. (2009). miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.
  29. (2009). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
  30. (2009). miR221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
  31. (2007). Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
  32. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
  33. (1997). Regulation of neuronal survival by the serine-threonine protein kinase Akt.
  34. (2010). Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes.
  35. (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
  36. (2003). The alteration of PTEN tumor suppressor expression and its association with the histopathological features of human primary hepatocellular carcinoma.
  37. (2008). The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
  38. (2009). Transformation of human liver LO2 cells mediated by stable HBx transfection.
  39. (2009). Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.
  40. (2010). Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.
  41. (2003). Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions.